ChemInform Abstract: 1,8‐Diazabicyclo(5.4.0)undecene‐Mediated Transesterification of p‐ Nitrophenyl Phosphonates: A Novel Route to Phosphono Esters.

Tawfik, Dan S.; Eshhar, Zelig; Bentolila, Alfonso; Green, B. S.

doi:10.1002/chin.199411222

Cited by 1 publication

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The synthesis of fluorophosphonate 3 is depicted in Figure 2 and commences with the standard three-step conversion of 11bromoundecanol (4) into N-Boc-11-aminoundecan-1-ol (5). Treatment of the latter compound with di-p-nitrophenyl methylphosphonate and DBU gave methylphosphonate 6 in good overall yield (21). At this stage, the O-p-nitrophenyl group in (6) was substituted for fluorine using tetrabutylammonium triphenyldifluorosilicate (TBAT) as the dry fluorine source, giving fluorophosphonate 7 in 70% yield.…”

Section: Resultsmentioning

confidence: 99%

Activity-Based Protein Profiling Reveals Broad Reactivity of the Nerve Agent Sarin

Tuin

Mol

Berg

et al. 2009

Chem. Res. Toxicol.

View full text Add to dashboard Cite

Elucidation of noncholinesterase protein targets of organophosphates, and nerve agents in particular, may reveal additional mechanisms for their high toxicity as well as clues for novel therapeutic approaches toward intoxications with these agents. Within this framework, we here describe the synthesis of the activity-based probe 3, which contains a phosphonofluoridate moiety, a P-Me moiety, and a biotinylated O-alkyl group, and its use in activity-based protein profiling with two relevant biological samples, that is, rhesus monkey liver and cultured human A549 lung cells. In this way, we have unearthed eight serine hydrolases (fatty acid synthase, acylpeptide hydrolase, dipeptidyl peptidase 9, prolyl oligopeptidase, carboxylesterase, long-chain acyl coenzyme A thioesterase, PAF acetylhydrolase 1b, and esterase D/S-formyl glutathione hydrolase) as targets that are modified by the nerve agent sarin. It is also shown that the newly developed probe 3 might find its way into the development of alternative, less laborious purification protocols for human butyrylcholinesterase, a potent bioscavenger currently under clinical investigation as a prophylactic/therapeutic for nerve agent intoxications.

show abstract

Section: Resultsmentioning

confidence: 99%